Adverse reactions to monoclonal agents used in the treatment of cancer

Q4 Medicine

Adverse Drug Reaction Bulletin Pub Date : 2012-12-01 DOI:10.1097/FAD.0b013e32835ccbf1

Christopher M. Jones, J. Pascoe, J. Coleman

引用次数: 0

Abstract

SummaryMonoclonal agents have been developed to specifically target cancer cells but they can have systemic adverse effects which can be life-threatening, particularly infusion reactions, immunosuppression, tumour lysis syndrome, profound hypertension, cardiac failure and haematological toxicity.

查看原文本刊更多论文

单克隆药物治疗癌症的不良反应

单克隆药物已被开发用于特异性靶向癌细胞，但它们可能具有危及生命的全身不良反应，特别是输注反应、免疫抑制、肿瘤溶解综合征、深度高血压、心力衰竭和血液毒性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Adverse Drug Reaction Bulletin Medicine-Pharmacology (medical)

CiteScore

0.70

自引率

0.00%

发文量

期刊介绍： For over 40 years, Adverse Drug Reaction Bulletin has provided comprehensive coverage in the field of adverse drug reactions. Each issue contains an invited article on a topic of current interest, dealing with specific conditions from drug-induced lung disorders to drug-induced sexual dysfunction, or types of drugs from lipid-lowering agents to poisons antidotes. This bimonthly journal"s articles are timely, succinct and fully referenced